Killed vs. Modified-Live Vaccines
Introduction
For some antigens, veterinarians have to decide whether to use a killed
vaccine or a modified-live vaccine. Each vaccine has its advantages, and each
has its disadvantages. Most killed vaccines contain an adjuvant system, whose
purpose is to stimulate an immune response. Without an adjuvant, the body is
less likely to produce an effective response to the disease antigen. This
discussion will cover the differences between killed and modified-live vaccines.
Commentary
In order to make an informed decision regarding killed and modified-live
vaccines, it is important to know the generally accepted characteristics of
each type of vaccine advantage and disadvantage.
| Killed Vaccine |
| No reversion to virulence |
Two doses often needed for initial response |
| Safe in pregnant animals |
|
| Safe in immunocompromised animals |
|
| No shedding of the virus |
|
| Modified-live Vaccine |
| Less frequent transient adverse responses than killed vaccine |
Higher potential for vaccine-induced disease |
| Parenteral or mucosal administration |
Vaccinal virus shed |
|
Viral replication implies:
- Possible risk in pregnant animals
- Possible risk in immunocompromised animals
|
|
Short shelf life when reconstituted |
|
Easily inactivated by mishandling |
| Summary of Vaccine Antigen Presentations |
| Distemper |
MLV |
MLV |
R |
MLV |
MLV |
| Parvo |
MLV |
MLV |
MLV |
MLV |
MLV |
| Adenovirus |
MLV |
MLV |
MLV |
MLV |
MLV |
| Parainfluenza |
MLV |
MLV |
MLV |
MLV |
MLV |
| Corona |
K-A |
K-A |
MLV |
K-A |
K-A |
| Lepto |
K-A |
K-A |
K-A |
K-A |
K-A |
| Lyme |
K-A |
K-A |
R |
K-A |
K-A |
| Panleukopenia |
K-A & MLV |
MLV |
MLV |
MLV |
MLV |
| Calici |
K-A & MLV |
MLV |
MLV |
MLV |
MLV |
| Herpes |
K-A & MLV |
MLV |
MLV |
MLV |
MLV |
| Chlamydia |
K-A |
MLV |
MLV |
MLV |
MLV |
| Leukemia |
K-A |
K-A |
K-NA |
K-A |
K-NA |
| Rabies |
K-A |
K-A |
K-A & R |
K-A |
K-A |
| Key |
| MLV | Modified-live |
| K-A | Killed adjuvanted |
| K-NA | Killed with no adjuvant |
| R | Recombinant |